米纳瑞斯制药 MLYS
$15.33 +$0.09 (+0.59%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $15.33 0.00%
开盘$15.23
昨收$15.24
当日区间$14.91 – $15.65
成交量1.34M
市值$1.36B
市盈率（TTM）–
股息率–
财报
财报日平均波动±5.7%近15次财报
收涨次数5 / 1533% 的概率
最佳反应+10.0%
最差反应-22.8%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 11 Aug 2026 | After Market | ±7.5% | -1.02% | 符合区间 |
| 2026/Q1 | 6 May 2026 | After Market | ±13.3% | -2.56% | 符合区间 |
| 2025/Q4 | 12 Mar 2026 | After Market | ±12.2% | -2.96% | 符合区间 |
| 2025/Q3 | 10 Nov 2025 | After Market | ±10.3% | +5.87% | 符合区间 |
| 2025/Q2 | 12 Aug 2025 | After Market | ±17.4% | +0.37% | 符合区间 |
| 2025/Q1 | 12 May 2025 | After Market | ±12.3% | +1.20% | 符合区间 |
| 2024/Q4 | 12 Feb 2025 | Pre Market | – | +10.04% | – |
| 2024/Q3 | 11 Nov 2024 | After Market | – | -10.32% | – |
| 2024/Q2 | 13 Aug 2024 | After Market | ±37.6% | -22.82% | 符合区间 |
| 2024/Q1 | 9 May 2024 | Pre Market | ±32.0% | -2.59% | 符合区间 |
| 2023/Q4 | 21 Mar 2024 | Pre Market | – | -2.24% | – |
| 2023/Q3 | 7 Nov 2023 | After Market | – | -6.74% | – |
| 2023/Q2 | 7 Aug 2023 | After Market | – | +6.96% | – |
| 2023/Q1 | 15 May 2023 | After Market | – | -4.57% | – |
| 2022/Q4 | 15 Mar 2023 | After Market | – | -5.93% | – |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$246.04M-426.3% YoY
净利润-$241.07M-457.1% YoY
摊薄每股收益-$2.85-331.8% YoY
自由现金流-$32.56M-7.9% YoY
经营现金流-$32.56M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
净资产收益率-80.9%
资产收益率-69.7%
投入资本回报率-85.8%
流动比率34.46
负债/资产比率17.5%
现金及投资$661.41M
净现金（净负债）$661.41M
暂无评论——快来第一个聊聊 MLYS。
登录后参与讨论。